1. Home
  2. PLXS vs STVN Comparison

PLXS vs STVN Comparison

Compare PLXS & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PLXS

Plexus Corp.

HOLD

Current Price

$196.67

Market Cap

5.3B

Sector

Technology

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$15.88

Market Cap

5.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLXS
STVN
Founded
1979
1949
Country
Employees
N/A
N/A
Industry
Electrical Products
Containers/Packaging
Sector
Technology
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
5.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PLXS
STVN
Price
$196.67
$15.88
Analyst Decision
Buy
Hold
Analyst Count
4
2
Target Price
$194.00
$23.75
AVG Volume (30 Days)
426.4K
1.0M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
0.40%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.26
$8.42
Revenue Next Year
$8.18
$9.61
P/E Ratio
$30.46
$26.70
Revenue Growth
N/A
N/A
52 Week Low
$103.43
$13.91
52 Week High
$211.84
$28.00

Technical Indicators

Market Signals
Indicator
PLXS
STVN
Relative Strength Index (RSI) 58.04 40.83
Support Level $193.49 $15.43
Resistance Level $211.84 $16.69
Average True Range (ATR) 10.07 0.99
MACD -1.15 0.19
Stochastic Oscillator 60.44 60.60

Price Performance

Historical Comparison
PLXS
STVN

About PLXS Plexus Corp.

Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

Share on Social Networks: